Sort   by:  
 Page size 
UnknownCSF proteomics identifies early changes in autosomal dominant Alzheimer's disease.
Not available
S-EPMC11531390 | biostudies-literature
UnknownCerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.
Not available
S-EPMC10427428 | biostudies-literature
UnknownCortical asymmetry in autosomal dominant Alzheimer's disease progression.
Not available
S-EPMC12781868 | biostudies-literature
UnknownA Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
Not available
S-EPMC7060076 | biostudies-literature
UnknownDe novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population.
Not available
S-EPMC7007577 | biostudies-literature
UnknownSeverity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Not available
S-EPMC4309077 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
Sort   by:  
 Page size